Ocular distribution, bactericidal activity and settling characteristics of TobraDex® ST ophthalmic suspension compared with TobraDex® ophthalmic suspension

Advances in Therapy

Volumn 25, Issue 2, 2008, Pages 77-88

  Scoper, Stephen V ^a   Kabat, Alan G ^b   Owen, Geoffrey R ^c   Stroman, David W ^c   Kabra, Bhagwati P ^c   Faulkner, Robert ^c   Kulshreshtha, Alok K ^c   Rusk, Cindy ^c   Bell, Belinda ^c   Jamison, Tiffany ^c   Bernal Perez, Lina F ^c   Brooks, Amy C ^c   Nguyen, Vincent A ^c  

^a Virginia Eye Consultants   (United States)

^b NOVA SOUTHEASTERN UNIVERSITY   (United States)

^c ALCON RESEARCH LTD   (United States)

Author keywords

Aqueous humour; Corticosteroid; Dexamethasone; Pharmacokinetics; Tear film; Tobramycin

Indexed keywords

DEXAMETHASONE PLUS TOBRAMYCIN; TOBRADEX ST; UNCLASSIFIED DRUG; DEXAMETHASONE; EYE DROPS; TOBRAMYCIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS HUMOR; ARTICLE; BACTERIAL EYE INFECTION; BACTERICIDAL ACTIVITY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG DOSAGE FORM COMPARISON; DRUG DOSE COMPARISON; DRUG INDICATION; DRUG TISSUE LEVEL; EYE INFLAMMATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; RABBIT; STREPTOCOCCUS PNEUMONIA; SUSPENSION; TEAR FILM; TREATMENT DURATION; VISCOSITY; ANIMAL; ANTIBIOTIC RESISTANCE; CATARACT; CHEMISTRY; DRUG COMBINATION; DRUG EFFECT; EYE; LACRIMAL FLUID; METABOLISM; STREPTOCOCCUS PNEUMONIAE;

ADULT; ANIMALS; CATARACT; DEXAMETHASONE; DRUG COMBINATIONS; DRUG RESISTANCE, BACTERIAL; EYE; FEMALE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; OPHTHALMIC SOLUTIONS; RABBITS; STREPTOCOCCUS PNEUMONIAE; SUSPENSIONS; TEARS; TOBRAMYCIN;

EID: 58749112560     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12325-008-0019-9     Document Type: Article

References (12)

1. Kim JY, Ali R, Cremers SL, Henderson BA. Perioperative prophylaxis for postcataract extraction endophthalmitis. Int Ophthalmol Clin. 2007;47:1-14.
2. Wirbelauer C. Management of the red eye for the primary care physician. Am J Med. 2006;119:302-306.
3. Kowalski RP, Yates KA, Romanowski EG, Karenchak LM, Mah FS, Gordon YJ. An ophthalmologist's guide to understanding antibiotic susceptibility and minimum inhibitory concentration data. Ophthalmology. 2005;112:1987.
4. Lichtenstein SJ, Wagner RS, Jamison T, Bell B, Stroman DW. Speed of bacterial kill with a fluoroquinolone compared with nonfluoroquinolones: clinical implications and a review of kinetics of kill studies. Adv Ther. 2007;24:1098-1112.
5. Owen GR, Brooks AC, James O, Robertson SM. A novel in vivo rabbit model that mimics human dosing to determine the distribution of antibiotics in ocular tissues. J Ocul Pharmacol Ther. 2007;23:335-342.
6. Levine JM, Noecker RJ, Lane LC, Herrygers L, Nix D, Snyder RW. Comparative penetration of moxifloxacin and gatifloxacin in rabbit aqueous humor after topical dosing. J Cataract Refract Surg. 2004;30:2177-2182.
7. Robertson SM, Curtis MA, Schlech BA, et al. Ocular pharmacokinetics of moxifloxacin after topical treatment of animals and humans. Surv Ophthalmol. 2005;50(suppl 1):S32-S45.
8. Wagner RS, Abelson MB, Shapiro A, Torkildsen G. Evaluation of moxifloxacin, ciprofloxacin, gatifloxacin, ofloxacin, and levofloxacin concentrations in human conjunctival tissue. Arch Ophthalmol. 2005;123:1282-1283.
9. Rhee SS, Mah FS. Comparison of tobramycin 0.3%/dexamethasone 0.1% and tobramycin 0.3%/loteprednol 0.% in the management of blepharo-keratoconjunctivitis. Adv Ther. 2007;24:60-67.
10. Notivol R, Amin D, Whitling A, Wells D, Kennedy M, Cockrum PC. Prophylactic effectiveness of tobramycin-dexamethasone eye drops compared with tobramycin/vehicle eye drops in controlling post-surgical inflammation in cataract patients: Prospective, randomised, double-masked, two-arm, parallel-group, placebo-controlled, multicentre study. Clin Drug Invest. 2004;24:523-533.
11. Notivol R, Bertin D, Amin D, Whitling A, Kennedy M, Cockrum PC. Comparison of topical tobramycin-dexamethasone with dexamethasone-neomycin-polymyxin and neomycin-polymyxin-gramicidin for control of inflammation after cataract surgery: Results of a multicenter, prospective, three-arm, randomized, double-masked, controlled, parallel-group study. Clin Ther. 2004;26:1274-1285.
12. Tobramycin. In: US Pharmacopoeia (USP31, NF 26). Rockville, MD: United States Pharmacopeial Convention; 2008;3:3418-3419.